Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
Saved in:
| Title: | Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma. |
|---|---|
| Authors: | Zheng BH; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Shen S; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Wong KF; Arbele Limited, Biotech Center, Hong Kong, China., Gong ZJ; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Sun WT; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Ni XJ; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Wang JW; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Hu MY; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Liu H; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Ni XL; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Liu HB; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China., Luk JM; Arbele Limited, Biotech Center, Hong Kong, China., Suo T; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, Shanghai, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.; Biliary Tract Disease Institute, Fudan University, Shanghai, China. |
| Source: | Journal of surgical oncology [J Surg Oncol] 2021 Apr; Vol. 123 (5), pp. 1253-1262. Date of Electronic Publication: 2021 Feb 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-9098 |
|---|---|
| DOI: | 10.1002/jso.26399 |
